Literature DB >> 35070429

Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.

Xiaojuan Zhao1, Jingge Zhao2, Lianyuan Tao3, Yujin Pan3, Long Yang1, Xijun Zhang1, Jianjun Yuan1, Haohui Zhu1.   

Abstract

BACKGROUND: Vascular invasion is an important risk factor of poor prognosis in hepatocellular carcinoma (HCC) patients. The detection of circulating tumor cells (CTCs) in the blood is direct evidence of tumor presence. There are few reports on CTCs and metastasis and vascular invasion of HCC. The purpose of this study was to analyze the significance of CTCs in the portal vein regarding metastases and vascular invasion in HCC patients.
METHODS: A total of 104 HCC patients diagnosed and treated in Zhengzhou University People's Hospital were enrolled. Surgery was performed in 60 individuals. Portal vein blood samples were collected before treatment for CTCs detection. We used the isolation by size of epithelial tumor cells (ISET) and fluorescence in situ hybridization (FISH) to enrich and classify CTCs from blood samples. The patients were divided into metastasis and nonmetastasis groups according to the metastasis status before treatment. Differences in clinical indicators such as alpha-fetoprotein (AFP) levels, tumor size, CTCs count, and macrovascular tumor thrombus between the two groups were analyzed as well as the associations of CTCs count with the above indicators. For individuals with postoperative pathology, the relationship between CTCs counts and microvascular invasion (MVI) was analyzed.
RESULTS: The amounts of portal vein CTCs were higher in patients with metastases compared with the nonmetastases group (20 vs. 7; z=3.795; P<0.001). Multivariate logistic regression analysis showed that the CTC count was a risk factor for HCC metastasis [odds ratio (OR) =1.044; 95% CI: 1.011-1.079]. The sensitivity and specificity of CTC count in predicting HCC metastasis were 82.93% and 52.38%, respectively. CTC count was significantly correlated with tumor size (rs=0.308; P=0.001), vascular invasion (z=4.211; P<0.001), and MVI (z=12.763; P=0.002). A threshold CTC count of seven showed the most significant power for predicting metastasis.
CONCLUSIONS: Vascular invasion positivity was closely related to HCC metastasis. Portal vein CTC count before treatment was correlated with vascular invasion and could be considered one of the factors affecting HCC metastasis. However, the ability of CTC count was limited in predicting HCC metastasis due to insufficient specificity. 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Portal vein; circulating tumor cell (CTC); hepatocellular carcinoma (HCC); metastasis; vascular invasion

Year:  2021        PMID: 35070429      PMCID: PMC8748049          DOI: 10.21037/jgo-21-734

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  35 in total

Review 1.  Angiogenesis in chronic liver disease and its complications.

Authors:  Stephanie Coulon; Femke Heindryckx; Anja Geerts; Christophe Van Steenkiste; Isabelle Colle; Hans Van Vlierberghe
Journal:  Liver Int       Date:  2010-11-15       Impact factor: 5.828

Review 2.  Liquid biopsy in breast cancer: A comprehensive review.

Authors:  Sahar Alimirzaie; Maryam Bagherzadeh; Mohammad R Akbari
Journal:  Clin Genet       Date:  2019-02-27       Impact factor: 4.438

3.  Circulating biomarkers in hepatocellular carcinoma.

Authors:  Karen L Morris; Jonathan D Tugwood; Leila Khoja; Matthew Lancashire; Robert Sloane; Debbie Burt; Patrick Shenjere; Cong Zhou; Clare Hodgson; Toshihiko Ohtomo; Atsuhiko Katoh; Takahiro Ishiguro; Juan W Valle; Caroline Dive
Journal:  Cancer Chemother Pharmacol       Date:  2014-06-13       Impact factor: 3.333

4.  Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.

Authors:  Lu-Nan Qi; Bang-De Xiang; Fei-Xiang Wu; Jia-Zhou Ye; Jian-Hong Zhong; Yan-Yan Wang; Yuan-Yuan Chen; Zu-Shun Chen; Liang Ma; Jie Chen; Wen-Feng Gong; Ze-Guang Han; Yan Lu; Jin-Jie Shang; Le-Qun Li
Journal:  Cancer Res       Date:  2018-06-18       Impact factor: 12.701

5.  Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma.

Authors:  Hidetoshi Nitta; Marc-Antoine Allard; Mylène Sebagh; Oriana Ciacio; Gabriella Pittau; Eric Vibert; Antonio Sa Cunha; Daniel Cherqui; Denis Castaing; Henri Bismuth; Catherine Guettier; Maité Lewin; Didier Samuel; Hideo Baba; René Adam
Journal:  Ann Surg Oncol       Date:  2019-05-03       Impact factor: 5.344

Review 6.  The Role of Angiogenesis in Hepatocellular Carcinoma.

Authors:  Michael A Morse; Weijing Sun; Richard Kim; Aiwu Ruth He; Paolo B Abada; Michelle Mynderse; Richard S Finn
Journal:  Clin Cancer Res       Date:  2018-10-01       Impact factor: 12.531

7.  Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.

Authors:  Yun-Fan Sun; Wei Guo; Yang Xu; Yin-Hong Shi; Zi-Jun Gong; Yuan Ji; Min Du; Xin Zhang; Bo Hu; Ao Huang; George G Chen; Paul B S Lai; Ya Cao; Shuang-Jian Qiu; Jian Zhou; Xin-Rong Yang; Jia Fan
Journal:  Clin Cancer Res       Date:  2017-10-25       Impact factor: 12.531

Review 8.  Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.

Authors:  Joseph C Ahn; Pai-Chi Teng; Pin-Jung Chen; Edwin Posadas; Hsian-Rong Tseng; Shelly C Lu; Ju Dong Yang
Journal:  Hepatology       Date:  2021-01-18       Impact factor: 17.425

Review 9.  Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.

Authors:  Qianwei Ye; Sunbin Ling; Shusen Zheng; Xiao Xu
Journal:  Mol Cancer       Date:  2019-07-03       Impact factor: 27.401

10.  Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.

Authors:  Kai Cui; Yang Ou; Yangyang Shen; Sheng Li; Ziqiang Sun
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.